University of Manchester and Owlstone Medical Awarded £250,000 to Advance Asthma Diagnostics
The study will collect breath samples from asthmatic patients and healthy controls to analyze breath-based biomarkers.
Read MorePosted by Steve Halasey | Mar 25, 2019 | Cardiovascular, Research, Respiratory Disease |
The study will collect breath samples from asthmatic patients and healthy controls to analyze breath-based biomarkers.
Read MorePosted by Chaunie Brusie | Mar 4, 2019 | Melanoma, Research |
Studies are demonstrating the potential of the Parsortix system to enhance laboratory efficiency, reduce costs, support medical decisionmaking, and improve patient care.
Read MorePosted by Steve Halasey | Jan 31, 2019 | Lung Cancer |
The companies’ collaboration underscores the need for proteomic data to enable precision medicine strategies for lung cancer patients.
Read MorePosted by Steve Halasey | Jan 17, 2019 | Lung Cancer |
If approved, the test could be the first FDA-approved multigene sequencing-based in vitro diagnostic to accept both plasma and FFPE-based inputs.
Read MorePosted by Steve Halasey | Jan 11, 2019 | Lung Cancer |
The assay enables researchers to measure tumor mutational burden and microsatellite instability, and detect other known and emerging biomarkers.
Read More